EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

AMPK : Accumulating Evidence in Support of its role in Dual Regulation of Vascular Function and Metabolism During Human Pregnancy

Lorna G Moore iD, Stephanie R Wesolowski, Ramón A Lorca, Colleen G Julian

Acta Physiologica · 2025

DOI: 10.1111/apha.70093 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Physiologica, 2025. Verfasst von Lorna G Moore und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Denver School of Medicine, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Placenta. Die Arbeit nennt 180 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIDDK NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adenosine monophosphate‐activated protein kinase (AMPK) serves to match perfusion with metabolism. Since pregnancy necessitates significant changes in both perfusion and metabolism for supporting fetal growth, surprising is that AMPK has received scant attention during pregnancy, perhaps due to the complexity of its actions and multiple maternal, placental, and fetal targets. Here we review human as well as experimental animal studies documenting AMPK activation's broad‐ranging maternal effects. Emphasized are those affecting vascular control and blood flow to the uteroplacental circulation under conditions of chronic hypoxia. Time and dosage‐dependent effects on the placenta and the fetus are also reviewed, revealing that AMPK activation affects all three—maternal, placental, and fetal—pregnancy compartments. We point to the need for an integrated study of AMPK's effects in each compartment during normal as well as fetal growth‐restricted (FGR) pregnancies. Since there are currently no therapies for FGR apart from early delivery, whereas there are drugs or nutritional substances activating AMPK approved for human use, such agents may represent new treatments. However, understanding their molecular mechanisms and specific actions in pregnancy compartments is required before conducting such trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AMP-Activated Protein KinasesPlacentaHumansPregnancyFemaleAnimalsFetal Growth RetardationPlacental CirculationFetus

Stichwörter der Autor:innen

blood flowcarbohydrate metabolismfetal growth restrictionhigh altitudehypoxiapreeclampsia

Substanzen

AMP-Activated Protein Kinases

Autor:innen und Institutionen

  • Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Denver School of Medicine, Aurora, Colorado, USA.
  • Section of Neonatology, Department of Pediatrics, University of Colorado Denver School of Medicine, Aurora, Colorado, USA.
  • Department of Biomedical Informatics, University of Colorado Denver School of Medicine, Aurora, Colorado, USA.

ORCID-Profile: Lorna G Moore

Förderung

  • NIH HHS
  • NIDDK NIH HHS
  • NICHD NIH HHS
  • NHLBI NIH HHS
  • National Institutes of Health

Zitieren

APA

Moore, L. G., Wesolowski, S. R., Lorca, R. A., & Julian, C. G. (2025). AMPK : Accumulating Evidence in Support of its role in Dual Regulation of Vascular Function and Metabolism During Human Pregnancy. Acta Physiologica. https://doi.org/10.1111/apha.70093

Vancouver

Moore LG, Wesolowski SR, Lorca RA, Julian CG. AMPK : Accumulating Evidence in Support of its role in Dual Regulation of Vascular Function and Metabolism During Human Pregnancy. Acta Physiologica. 2025. doi:10.1111/apha.70093

BibTeX
@article{Moore2025,
  author = {Moore, Lorna G and Wesolowski, Stephanie R and Lorca, Ramón A and Julian, Colleen G},
  title = {AMPK : Accumulating Evidence in Support of its role in Dual Regulation of Vascular Function and Metabolism During Human Pregnancy},
  journal = {Acta Physiologica},
  year = {2025},
  doi = {10.1111/apha.70093}
}
Kostenlos starten →